Randall Kaye insider trades: Longboard Pharmaceuticals (LBPH) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Randall reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | LBPH | ↓ Sell | 16,667 | $59.03 | $984K | Direct | Oct 16, 2024 (1d) |
| Sep 16, 2024 | LBPH | ↓ Sell | 16,666 | $31.64 | $527K | Direct | Sep 16, 2024 (0d) |
| Aug 12, 2024 | LBPH | ↓ Sell | 16,667 | $34.73 | $579K | Direct | Aug 13, 2024 (1d) |
| Jun 25, 2024 | LBPH | ↓ Sell | 100 | $20.87 | $2K | By Spouse | Aug 13, 2024 (49d) |
| Jan 23, 2024 | LBPH | ↑ Buy | 100 | $24.82 | $2K | By Spouse | Aug 13, 2024 (203d) |
| Dec 23, 2015 | AXSM | ↑ Buy | 1,000 | $9.03 | $9K | By children | Dec 24, 2015 (1d) |
| Sep 9, 2011 | AVNR | ↓ Sell | 100,000 | $2.75 | $275K | Direct | Sep 13, 2011 (4d) |
| Jan 5, 2011 | AVNR | ↓ Sell | 10,000 | $4.05 | $41K | Direct | Jan 7, 2011 (2d) |
| Dec 6, 2010 | AVNR | ↓ Sell | 10,000 | $3.80 | $38K | Direct | Dec 8, 2010 (2d) |
| Nov 5, 2010 | AVNR | ↓ Sell | 10,000 | $4.76 | $48K | Direct | Nov 8, 2010 (3d) |
| Oct 5, 2010 | AVNR | ↓ Sell | 10,000 | $3.23 | $32K | Direct | Oct 5, 2010 (0d) |
| Sep 7, 2010 | AVNR | ↓ Sell | 10,000 | $2.70 | $27K | Direct | Sep 8, 2010 (1d) |
| Aug 18, 2010 | AVNR | ↓ Sell | 35,000 | $3.08 | $108K | Direct | Aug 20, 2010 (2d) |
| Aug 5, 2010 | AVNR | ↓ Sell | 10,000 | $3.28 | $33K | Direct | Aug 9, 2010 (4d) |
| Jul 7, 2010 | AVNR | ↓ Sell | 10,000 | $3.02 | $30K | Direct | Jul 9, 2010 (2d) |
| Jun 7, 2010 | AVNR | ↓ Sell | 50,000 | $2.38 | $119K | Direct | Jun 8, 2010 (1d) |
| Sep 15, 2009 | AVNR | ↓ Sell | 2,000 | $2.10 | $4K | Indirect | Sep 15, 2009 (0d) |
| Sep 11, 2009 | AVNR | ↑ Buy | 2,000 | $2.18 | $4K | Indirect | Sep 15, 2009 (4d) |
| Feb 23, 2009 | AVNR | ↑ Buy | 10,000 | $0.43 | $4K | Indirect | Feb 25, 2009 (2d) |
| May 26, 2006 | AVNR | ↑ Buy | 2,000 | $10.14 | $20K | Direct | May 26, 2006 (0d) |
| May 26, 2006 | AVNR | ↑ Buy | 250 | $9.90 | $2K | by Son | May 26, 2006 (0d) |
| May 26, 2006 | AVNR | ↑ Buy | 250 | $9.90 | $2K | by Daughter | May 26, 2006 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Randall Kaye's insider trades
Randall Kaye is Executive Vice President & CMO at Longboard Pharmaceuticals (LBPH). Since May 26, 2006, Randall has reported 7 open-market purchases worth $45K and 15 sales worth $2.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares withheld for taxes (15 filings), grants and awards (11 filings), option exercises (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LBPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.